Minerva Neurosciences, Inc. (NERV)

Minerva Neurosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	22	43	8	34	100	277
Market Cap Growth	111.17%	406.54%	-75.19%	-65.73%	-64.01%	5.91%
Enterprise Value	-13	2	-28	-27	75	232
PE Ratio	-	-1.43	-0.26	-0.69	51.45	-3.84
PS Ratio	-	-	-	-	2.42	-
PB Ratio	-0.49	-1.51	-0.42	4.29	1.90	9.99
P/FCF Ratio	-0.87	-2.91	-0.34	-1.39	-2.95	-6.39
P/OCF Ratio	-0.87	-2.91	-0.34	-1.39	-2.95	-6.39
EV/Sales Ratio	-	-	-	-	1.81	-
EV/EBITDA Ratio	0.53	-0.07	0.86	0.52	35.20	-3.12
EV/EBIT Ratio	0.53	-0.07	0.86	0.52	38.39	-3.11
EV/FCF Ratio	0.81	-0.14	1.12	1.08	-2.20	-5.34
Debt / Equity Ratio	-	-	-	-	0.00	0.01
Debt / EBITDA Ratio	-	-	-	-	0.05	0.00
Debt / FCF Ratio	-	-	-	-	0.00	-0.01
Quick Ratio	12.34	12.28	26.27	21.59	8.06	6.93
Current Ratio	12.58	12.57	29.15	22.07	8.68	7.11
Asset Turnover	0	0	0	0	0.64	0
Return on Equity (ROE)	129.50%	137.00%	296.00%	-169.80%	4.20%	-126.60%
Return on Assets (ROA)	-53.20%	-50.30%	-51.30%	-50.90%	3.00%	-65.90%
Return on Capital (ROIC)	66.83%	81.24%	126.00%	-568.80%	3.50%	-270.33%
Earnings Yield	-143.92%	-69.76%	-378.15%	-145.84%	1.94%	-26.01%
FCF Yield	-94.55%	-34.38%	-290.45%	-71.89%	-33.87%	-15.65%
Buyback Yield / Dilution	-41.74%	-21.84%	0.00%	-4.41%	-4.88%	-0.57%
Total Shareholder Return	-41.74%	-21.84%	0.00%	-4.41%	-4.88%	-0.57%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).